Over the past five
years oncology research has exploded, with fast - paced development schedules delivering breakthrough drugs that are changing the standard of care.
Not exact matches
Immunotherapy has been emerging from the backdrop of
oncology research for
years most notably from smaller companies such as Dendreon, Kite Pharma and Juno Therapeutics as leaders in the space.
His interest in
research grew while he did his medical degree at Stanford, so he enrolled in Stanford's
research - residency program, which allowed him to do 2
years of traditional residency training with a 3rd -
year research fellowship in hematology -
oncology.
For men with intermediate risk prostate cancer, side effects at two
years following radiation therapy (RT) were comparable for extremely - hypofractionated treatment, which was delivered in seven fractions across two and a half weeks, and conventional treatment of 39 fractions across eight weeks, according to
research presented at the 58th Annual Meeting of the American Society for Radiation
Oncology (ASTRO).
People diagnosed with cancer gained 3.34 million
years of life thanks to cancer clinical trials run by SWOG and supported with public funds, according to new study results to be presented at the 53rd Annual Meeting of the American Society of Clinical
Oncology (ASCO), the world's largest clinical cancer
research meeting.
Beyond its $ 100 - millionper -
year platform
research, Moderna runs four wholly owned ventures focused on drugs for infectious diseases, rare diseases, immuno -
oncology, and personalized cancer vaccines.
She worked with Ganz for 3
years as a junior scientist, learning about cancer and chronic disease and charting a course in the relatively new field of psycho -
oncology before applying for her own
research funding.
However, what our trial has shown is that although this is still the case, the proportion of women who will actually have a recurrence without radiotherapy is very small (less than 5 percent), five
years after treatment,» said Ian Kunkler, F.R.C.R., professor of clinical
oncology at the Edinburgh Cancer
Research Center in the University of Edinburgh.
As a first -
year hematology -
oncology fellow at Dana - Farber / Partners CancerCare 10
years ago, Catherine Wu recognized that if she wanted to bridge
research and clinical practice, she needed to understand her options.
Previously described as the «guardian of the genome» and voted «Molecule of the
Year» in 1993, p53 is one of the most important proteins regulating cell growth and a major focus for
oncology research.
Now in the second
year of her PhD in Silvio Parodi's experimental
oncology group at the National Institute for Cancer
Research in Genoa, Stefania Pasa (see photo) was a studious child who often «preferred to... study rather than go out to the cinema.»
Commenting on the significance of the
research, Dr Pilar Garrido, head of the Thoracic Tumour Section of the Medical
Oncology Department at Ramón y Cajal University Hospital, Madrid, Spain, said: «Lung cancer is the most common cancer globally, but debate about the optimal screening strategy is ongoing and current selection criteria are based only on age and pack -
years.
Based on our findings, the occurrence of cancer is much higher in adults over 75
years of age compared with the proportion of patients in this age group who enroll in clinical trials,» said lead study author Bindu Kanapuru, MD, medical officer in the Division of Hematology Products, Office of Hematology and
Oncology Products in the US Food and Drug Administration's (FDA) Center for Drug Evaluation and
Research, who presented the results at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition, held December 9 — 12 in Atlanta.
Prior to that, Graziano spent five
years working in academic
research at New York University's School of Medicine, studying
oncology and cardiovascular diseases.
Lead author Professor Ledermann, professor of medical
oncology at the UCL Cancer Institute and a Cancer
Research UK grantee, said: «A well - tolerated anti-tumour agent that could be used for months or perhaps
years as maintenance therapy after standard chemotherapy could be a big step forward and ultimately extend survival.
The article is the culmination of an over
year - long collaborative effort convened by the two organizations alongside leaders in both
oncology and immunotherapy to author a paper with the intent of furthering and guiding colorectal cancer
research.
NRG
Oncology builds upon our more than 150
years of cumulative
research experience to conduct practice defining, multi-institutional clinical trials resulting in the improved survival and quality of life of patients with cancer.
Antibodies to a high - risk type of human papillomavirus (HPV16) could help detect oropharyngeal (1) cancer several
years before the clinical onset of the disease, reveals a new study from the International Agency for
Research on Cancer (IARC) in cooperation with the German Cancer
Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical
Oncology.
Bronson, who has been a nurse for over 30
years and currently works as a clinical
research oncology nurse in Highland Park, Illinois, says the coaching strategies and coach - client relationship taught by FMCA was completely different from the nurse - patient relationship.
Jersey City Walk for comparative
oncology research, but Jude also enlisted Big Paws Pet Care for a Cause as the major sponsor of the event — that
year and every
year since.
Sierra has volunteered and fundraised over the past 3
years for 2 Million Dogs, which focuses primarily on
oncology research in canines.
Her
research, which has been accepted by the European Journal of
Oncology and is slated for publication later this
year, consisted of plugging a DECT phone into both a live outlet and a dead outlet (used as a control), and monitoring the subject's heart rate.
According to a special
research paper on the prevalence of cancer in India which was printed in Lancet
Oncology journal, by 2035, these numbers may increase substantially and 17 lakh fresh patients may be diagnosed with cancer, with about 12 lakh people dying from it every
year.
Profile Thirteen
years of nursing experience in
oncology, clinical
research and ambulatory care (Effective communicator and results - oriented team player with extensive cross-cultural experience (A demonstrated ability to collaborate in diverse settings -LRB-
My long and diverse nursing career involving: clinical nursing (general medical - surgical,
oncology, and neurology), 12
years of clinical
research conduct, 6
years of
research regulatory review, professional publications, clinical
research management masters education preparation, and specialized
research certifications prepare me to perform in high level positions involving
research quality control and regulatory oversight.
COVER LETTER: To whom it concerns: Please consider the following skill set: * Eleven
years as the Medical Science Liaison (MSL) and Founding Chief Science Officer for Mitomics Inc (DBA as MTDNA Life Sciences), an
Oncology Biomarker Discovery Company: o Worked with physicians to increase market uptake of company products o Helped design marketing material for both consumers and physicians o Researched oncology markets f
Oncology Biomarker Discovery Company: o Worked with physicians to increase market uptake of company products o Helped design marketing material for both consumers and physicians o
Researched oncology markets f
oncology markets for hi...
SUMMARY: * rn, bsn, cpm, * Over 28
years of Clinical
Research experience * Respiratory, Ophthalmology,
Oncology, Infectious Disease, Cardiovascular, CNS and Gastrointestinal * Phase I, II and III experiences * 14
years of Clinical Trial / Project Management experience * 4
years of field monitoring experience * 14
years of experience providing oversight to CTAs and CRAs PurDue PharmA July 2017 - present Sr Clinical Project Man...
Pharmaceutical
research scientist with 34 years of experience in the area of oncology, twenty - five of them doing drug discovery research in the Cancer Department at Merck Resear
research scientist with 34
years of experience in the area of
oncology, twenty - five of them doing drug discovery
research in the Cancer Department at Merck Resear
research in the Cancer Department at Merck
ResearchResearch Labs.
SUMMARY: 30
years Clinical
Research and home - based monitoring experience 12
years Oncology monitoring experience 12
years Pediatric Nurse experience Largest workload: 5 - 6 protocols with 10 - 15 sites in
Oncology - Non-Small Cell Lung - Phase III, Neurology - Multiple Sclerosis - Phase III while at EMD Serono 10
years experience with Inform EDC and 6 months experience with IMedidata Located 20 minutes from Baltimore Washington Inter...